tirzepatide and diabetes FDA approves tirzepatide, Eli Lilly's new type 2 drug, the company shares an estimated price Tirzepatide (Mounjaro): Type 2 Diabetes

Physician-supervised GLP-1 therapy

Ibuprofen (200400 mg every 68 hours with food, maximum 1.2g in 24 hours for over-the-counter use) is an alternative, though it should be used cautiously if you have a history of gastrointestinal issues, peptic ulcers, renal impairment, or if you're dehydrated

The hormone stimulates glucose-dependent insulin secretion from pancreatic beta cells, meaning insulin release occurs only when blood glucose levels are elevated

Because bile acid signaling can influence enteroendocrine function and incretin-related pathways, this mechanism is particularly relevant when considering GLP-1 receptor agonists and dual GIP/GLP-1 receptor agonists (Xiang et al., 2026